Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
ZIMMER BIOMET HOLDINGS, INC.
Bear Case (25th pct.)
-20.1% vs price
Base Case (Median)
4.8% vs price
Bull Case (75th pct.)
43.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $258.33 | 192.6% | High (40%) |
| PE Comparable | $92.51 | 4.8% | Medium (25%) |
| Growth Trajectory DCF | $132.11 | 49.6% | Medium (20%) |
| Graham Number | $78.26 | -11.4% | Medium (40%) |
| EV/EBITDA | $62.88 | -28.8% | Medium (20%) |
| EV/FCF | $121.23 | 37.3% | Medium (20%) |
| Earnings Power Value | $47.47 | -46.2% | Medium (50%) |
Based on 7 out of 7 methods, ZBH appears fairly valued at the current price of $88.29. The base case fair value of $92.51 implies 4.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.